The recognition of tumor targets by NK cells does not rely on the MHC-peptide presentation, but rather on the induction of stress- and transformation-induced ligands on the surface of cancer cells, which often coincides with downregulation of MHC-class I molecules. This evidence concerns the gene HLA-C and neoplasm.